Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer

about

Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients

P2860

Q38697010-65E82785-A26E-4E4C-99CC-F99748D29950 Q58761759-EC9D8550-E066-4E76-A1F2-81FB0007469E

P2860

Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer

Item

http://www.wikidata.org/entity/Q37083038

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Loss of membranous VEGFR1 expr ...... ened survival in breast cancer

@en

Loss of membranous VEGFR1 expr ...... ned survival in breast cancer.

@nl

type

Item

label

Loss of membranous VEGFR1 expr ...... ened survival in breast cancer

@en

Loss of membranous VEGFR1 expr ...... ned survival in breast cancer.

@nl

prefLabel

Loss of membranous VEGFR1 expr ...... ened survival in breast cancer

@en

Loss of membranous VEGFR1 expr ...... ned survival in breast cancer.

@nl

P1476

Loss of membranous VEGFR1 expr ...... ened survival in breast cancer

@en

P2093

Alexander Quaas

http://www.w3.org/2001/XMLSchema#string

Andreas Holger Marx

http://www.w3.org/2001/XMLSchema#string

Annette Lebeau

http://www.w3.org/2001/XMLSchema#string

Christian Wilke

http://www.w3.org/2001/XMLSchema#string

Eike-Christian Burandt

http://www.w3.org/2001/XMLSchema#string

Fritz Jänicke

http://www.w3.org/2001/XMLSchema#string

Guido Sauter

http://www.w3.org/2001/XMLSchema#string

Julia Huber

http://www.w3.org/2001/XMLSchema#string

Luigi Terracciano

http://www.w3.org/2001/XMLSchema#string

Patrick Lebok

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

Angiogenesis in cancer, vascular, rheumatoid and other disease

Independent review of E2100: a phase III trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer.

VEGF targets the tumour cell.

A novel intracellular isoform of VEGFR-1 activates Src and promotes cell invasion in MDA-MB-231 breast cancer cells.

Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer.

Macrophages regulate the angiogenic switch in a mouse model of breast cancer.

P304

1443-1450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2016.5430

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27357606

http://www.w3.org/2001/XMLSchema#string

P932

4940099

http://www.w3.org/2001/XMLSchema#string

Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer

about

P2860

P2860

Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932